pyrroles has been researched along with glucagon-like peptide 1 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deacon, CF; Holst, JJ; Hughes, TE | 1 |
| Asano, O; Ikuta, H; Nagakura, T; Tanaka, I; Yamazaki, K; Yasuda, N; Yoshikawa, S | 1 |
| Deacon, CF; Holst, JJ; Møller, S; Plamboeck, A | 1 |
| Inoue, T; Kira, K; Nagakura, T; Saeki, T; Tanaka, I; Yamazaki, K; Yasuda, N | 2 |
| Aguilar-Bryan, L; Bryan, J; Crane, A; Hu, M; Nakazaki, M; Seghers, V; Ullrich, S | 1 |
| Ikuta, H; Nagakura, T; Tanaka, I; Yamazaki, K; Yasuda, N | 1 |
| Philips, JC; Radermecker, RP; Scheen, AJ | 1 |
| Ahrén, B; Hughes, TE | 1 |
| Bose, AK; Carr, RD; Mocanu, MM; Yellon, DM | 1 |
| Bijjem, KV; Goyal, S; Kumar, S; Singh, M | 1 |
| Ammala, CE; Boros, EE; Brashear, RL; Briscoe, CP; Bullard, SR; Caldwell, RD; Carpenter, AJ; Conlee, CR; Croom, DK; Hart, SM; Heyer, DO; Johnson, PR; Kashatus, JA; Katamreddy, SR; Minick, DJ; Peckham, GE; Roller, SG; Ross, SA; Samano, VA; Sauls, HR; Tadepalli, SM; Thompson, JB; Way, JM; Xu, Y | 1 |
| Droog, S; Havekes, LM; Maas, AC; Offerman, EH; Pieterman, EJ; Princen, HM; van den Hoek, AM; van den Hoogen, RM; van der Hoorn, JW; van Nieuwkoop, A | 1 |
13 other study(ies) available for pyrroles and glucagon-like peptide 1
| Article | Year |
|---|---|
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
Topics: Anesthetics; Animals; Dipeptidyl Peptidase 4; Drug Evaluation, Preclinical; Drug Synergism; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Infusions, Intravenous; Insulin; Insulin Secretion; Peptide Fragments; Protein Precursors; Pyrroles; Secretory Rate; Swine; Valine | 1998 |
Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats.
Topics: Animals; Blood Glucose; Dipeptidyl Peptidase 4; Duodenum; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Insulin; Insulin Secretion; Intubation, Gastrointestinal; Male; Peptide Fragments; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Rats, Mutant Strains; Species Specificity; Valine | 2001 |
GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.
Topics: Anesthesia; Animals; Blood Glucose; Chloralose; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Metabolic Clearance Rate; Peptide Fragments; Peptides; Protease Inhibitors; Protein Precursors; Pyrroles; Swine; Valine | 2002 |
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
Topics: Animals; Biguanides; Buformin; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Peptide Fragments; Phenformin; Protease Inhibitors; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Valine | 2002 |
cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Topics: Animals; ATP-Binding Cassette Transporters; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoquinolines; Mice; Mice, Knockout; Peptide Fragments; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Pyrroles; Receptors, Drug; Reference Values; Sulfonamides; Sulfonylurea Receptors | 2002 |
Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
Topics: Actins; Aging; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Insulin; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Proglucagon; Protease Inhibitors; Protein Precursors; Pyrroles; Valine | 2003 |
The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.
Topics: Animals; Antimetabolites; Biguanides; Dipeptidyl Peptidase 4; Enteroendocrine Cells; Fluorouracil; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Hypoglycemic Agents; Intestine, Small; Male; Metformin; Mice; Mice, Inbred BALB C; Organ Size; Peptides; Protease Inhibitors; Pyrroles; Rats; Rats, Inbred F344; Valine | 2004 |
[Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association].
Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Exenatide; Glucagon; Glucagon-Like Peptide 1; Heptanoic Acids; Humans; Islets of Langerhans Transplantation; Peptide Fragments; Peptides; Protein Precursors; Pyrroles; Venoms | 2004 |
Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptid
Topics: Animals; Dipeptidyl Peptidase 4; Female; Gastric Inhibitory Polypeptide; Gastrin-Releasing Peptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neuropeptides; Neurotransmitter Agents; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protease Inhibitors; Protein Precursors; Pyrroles; Valine | 2005 |
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway.
Topics: Animals; Blotting, Western; Disease Models, Animal; Enzyme Inhibitors; Glucagon-Like Peptide 1; In Vitro Techniques; Incretins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Protein Kinases; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Valine | 2007 |
Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Experimental; Endothelium, Vascular; Exenatide; Female; Glucagon-Like Peptide 1; Heptanoic Acids; Hyperhomocysteinemia; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Peptides; Pyrroles; Rats; Rats, Wistar; Venoms | 2010 |
Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
Topics: Administration, Oral; Animals; Cell Line; Colon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Incretins; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, G-Protein-Coupled; Stereoisomerism; Structure-Activity Relationship | 2012 |
APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Apolipoprotein E3; Atorvastatin; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Fenofibrate; Glucagon-Like Peptide 1; Heptanoic Acids; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Liraglutide; Male; Metabolic Syndrome; Mice, Transgenic; Niacin; Non-alcoholic Fatty Liver Disease; Obesity; Pyrroles; Rosiglitazone; Thiazolidinediones | 2014 |